A phase III trial of thymosin beta-4 in patients with epidermolysis bullosa
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Thymosin-beta-4 (Primary)
- Indications Epidermolysis bullosa
- Focus Therapeutic Use
- Sponsors G-treeBNT; ReGenTree
- 14 Feb 2018 Planned initiation date changed from 1 Jul 2017 to 1 Jan 2018, according to a RegeneRx Biopharmaceuticals media release.
- 14 Feb 2018 According to a RegeneRx Biopharmaceuticals media release, the trial is expected to initiate in 2018.
- 01 Mar 2017 New trial record